• Explore /
  • Poster
  • / Phase 2 study of neoadjuvant cabozantinib in patients with locally advanced non-metastatic clear cell renal cell carcinoma.

Phase 2 study of neoadjuvant cabozantinib in patients with locally advanced non-metastatic clear cell renal cell carcinoma.

Abstract Poster

Authors

Mehmet Asim Bilen

Mehmet Asim Bilen

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Mehmet Asim Bilen , Yuan Liu , Bassel Nazha , Jacqueline T Brown , Adeboya O. Osunkoya , Sierra Williams , Wilena Session , Lauren Beth Yantorni , Greta Russler , Sarah Caulfield , Shreyas S. Joshi , Vikram M. Narayan , Christopher Paul Filson , Kenneth Ogan , Omer Kucuk , Bradley Curtis Carthon , Haydn Kissick , Viraj A. Master

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04022343

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 340)

DOI

10.1200/JCO.2022.40.6_suppl.340

Abstract #

340

Poster Bd #

F10

Abstract Disclosures

Similar Posters

Poster

2014 Genitourinary Cancers Symposium

Phase II trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.

Phase II trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.

First Author: Jose A. Karam

First Author: Shun Zhang

First Author: Deepak Kilari

First Author: Deepak Kilari